Lirong Qu
Pittsburgh, PANPI 1245205707
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,207,600 of the $2,207,600 with a category attached, or 100.0%. Vitalant accounts for 91.2% of it on its own, with 2 other manufacturers making up the rest.
$2,207,600in general payments, 2019–2025
Across 67 payments — averaging $32,949 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vitalant$2M
- Institute For Transfusion Medicine$192K
- Itxm Clinical Services$1K
What the payments were for
- Speaking & faculty fees$2,207,600100%
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vitalant | 61 | $2,014,339 |
| Institute For Transfusion Medicine | 1 | $192,001 |
| Itxm Clinical Services | 5 | $1,260 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.